ClinicalTrials.gg
Drug

Eplerenone clinical trials

Also written Inspra.

studies test it
97
open now
18
in phase 3
18
first study started
2001

How each study uses Eplerenone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Eplerenone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Sept 2002 · INSPRA · NDA 021437 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Eplerenone
79
Epleronone
2
Eplerenone 50mg
2
Eplerenone 50 mg Tab
2
Eplerenone 50 mg Tablets Sandoz Inc., USA
2

Brand

Inspra
27

Studies by the year they started

95 studies that test it; most in 2013 (13); 2 more planned to start later

Studies that test Eplerenone, by start year
YearStudies
20011
20034
20044
20051
20066
20077
20082
20092
20105
20113
20123
201313
20146
20154
20165
20174
20181
20192
20202
20211
20223
20236
20241
20252
20267

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
8
Phase 2
19
Phase 3
18
Phase 4
38
No phase
16

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 83

Brigham and Women's Hospital (10) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (6) · Central Hospital, Nancy, France (3) · Massachusetts General Hospital (3) · Radboud University Medical Center (3) · Hippocration General Hospital (2) · Vanderbilt University Medical Center (2) · Vanderbilt University (2)

Often tested with

Tested in the same studies.

Spironolactone (5) · Amlodipine (4) · Aliskiren (3) · Valsartan (2) · Ramipril (2) · Chlorthalidone (2) · Vicadrostat (1) · Fludrocortisone (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7

Studies that test Eplerenone.

Studies

Open first, then newest update. How each study uses Eplerenone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 97

See all 97 studies that test Eplerenone →

Given beside what is tested · 2 — Eplerenone is usual care or a partner of the new treatment
As the comparator · 11 — what is tested is compared with Eplerenone

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Eplerenone · ClinicalTrials.gg INT006742

  • MeSH (NLM) D000077545EplerenoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 6995V82D0BEPLERENONEConfirmed FDA, NLM, Wikidata
  • RxNorm 298869Confirmed FDA, Wikidata
  • Wikidata Q423804eplerenoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47513EplerenoneConfirmed FDA, Wikidata
  • DrugBank DB00700One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.